corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 17374

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Report

Thompson J, Baird P, Downie J
Report of the Committee of Inquiry on the Case Involving Dr Nancy Oliveri, the Hospital for Sick Children, the University of Toronto, and Apotex Inc
2001 Oct 26
www.law.ualberta.ca/centres/hli/userfiles/10_2moelorifrm.pdf


Abstract:

THIS CASE INVOLVES ISSUES of research ethics and academic freedom so
important to the public interest that it has attracted national and international
attention. It occurred in a context that quickly developed from the mid-1980s to
the mid-1990s of increased pressures on universities, teaching hospitals and
individual researchers to seek corporate sponsorship for projects. Public
institutions were not conscious of the inadequacy of their policy infrastructures
for protecting the public interest in this new environment, and policies and
practices had not been changed to take into account the new circumstances.
It was possible for clinical investigators to sign contracts with industrial
sponsors for research trials containing provisions that protected the sponsors’
interests, but not the public interest or the safety of trial participants. This
meant a dispute could arise between the ethical and legal obligations of an
investigator to inform participants of unexpected risks, and the contractual
right of a sponsor to insist that information on risks not be communicated and
to terminate a trial without prior notice. The academic freedom of an
investigator to publish adverse findings and inform the scientific community
could be at issue.
Such a dispute arose in this case, and it was compounded by oversights,
mistakes or misjudgments by individuals, public institutions, a private
corporation, and inquiry panels. In some instances the mistakes were under-
standable, and are more clear with the benefit of hindsight and the full
documentation available to us. In other instances, serious wrongs were
committed. In these instances substantial redress and calling to account are
appropriate.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909